Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on April 16, 2025
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
GlobeNewswire
·
April 16, 2025
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine …
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
GlobeNewswire
·
April 16, 2025
CAMBRIDGE, Mass. and HOUSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts …
electroCore to Participate at the Planet MicroCap Showcase
GlobeNewswire
·
April 16, 2025
ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet MicroCap Showcase taking place at the Paris …
Richtech Robotics Announces an Agreement to Purchase an Approximately 20,000 Square Foot Property to Expand Its Headquarters
GlobeNewswire
·
April 16, 2025
New Las Vegas-based facility plans to increase manufacturing and assembly capacity by 400% and accommodate further integration of domestic supply chain Las Vegas, NV, April 16, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech …
Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 16, 2025
Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types Continued progress of lead program, AKTX-101, for the treatment of solid tumors Platform technology to fuel …
ThreatQuotient Celebrates Record Year Marked by Major Customer and Partner Growth, Product Innovation, and Industry Recognition
GlobeNewswire
·
April 16, 2025
Ashburn, VA. 16th April 2025 – ThreatQuotient, a leading innovator in threat intelligence platforms, has delivered exceptional growth and innovation over the past year. This growth has been fueled by increasing market demand for simplified security …
VertiGIS Appoints Greg Brazeau as its Leader in the USA and Chooses Denver for New US Utilities Headquarters
GlobeNewswire
·
April 16, 2025
New hub in the United States’ geospatial capital enables VertiGIS to streamline the deployment of its VertiGIS Networks solution for utilities. Denver, US. April 16th, 2025 – VertiGIS, a leading global provider of spatial asset management solutions, has …
Western Union Media Network Taps Magnite to Expand Advertising Capabilities
GlobeNewswire
·
April 16, 2025
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced an agreement with Western Union to support growth of the financial services company’s new Media Network business. In …
Melissa Accelerates FedRAMP Momentum with Webinar for Government IT Resellers
GlobeNewswire
·
April 16, 2025
RANCHO SANTA MARGARITA, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- In response to a changing regulatory landscape, Melissa is building on its FedRAMP® Authorization with a webinar to support IT value-added resellers (VARs) and government consultants. A …
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
GlobeNewswire
·
April 16, 2025
SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one of very few clinical trials for a Parkinson’s disease …
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
GlobeNewswire
·
April 16, 2025
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before …
BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer
GlobeNewswire
·
April 16, 2025
Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly exceeds historical data of 14.4 months in TRODELVY® (sacituzumab govitecan-hziy) in similar heavily pre-treated …
LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation
GlobeNewswire
·
April 16, 2025
Exemption from the $5.1 million repayment obligation strengthens LAVA’s balance sheet Underscores focus on cost curtailment and strategic option evaluation UTRECHT, The Netherlands and PHILADELPHIA, April 16, 2025 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V …
NextGen Digital Reiterates Its Strategic Plan to Build Significant Long-Term Value
GlobeNewswire
·
April 16, 2025
Fredericton, New Brunswick, April 16, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”), a technology company, today provides an update on its strategic priorities and corporate strategy. …
Avicanna Announces Revocation of Management Cease Trade Order
GlobeNewswire
·
April 16, 2025
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Draganfly Establishes Public Safety Advisory Board, Appoints Homeland Security and Law Enforcement Expert Paul Goldenberg as Chair
GlobeNewswire
·
April 16, 2025
Industry Veteran Joins Draganfly to Drive Innovation at the Intersection of Public Safety and Technology Tampa, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading …
Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough
GlobeNewswire
·
April 16, 2025
OXFORD, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Dr. Daniel Chen, at the University of Oxford and Chief Scientist at biotech startup Oxperial BioHealth, revealed their major breakthrough in cancer prevention—a sunlight-powered technology that …
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
GlobeNewswire
·
April 16, 2025
Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and Australia for systemic lupus erythematosus CAMBRIDGE, …
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
GlobeNewswire
·
April 16, 2025
CONSHOHOCKEN, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that …
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
GlobeNewswire
·
April 16, 2025
CHATHAM, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that …